Literature DB >> 15313517

Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.

Jean Théberge1, Yousef Al-Semaan, Dick J Drost, Ashok K Malla, Richard W J Neufeld, Robert Bartha, Rahul Manchanda, Ravi Menon, Maria Densmore, Betsy Schaefer, Peter C Williamson.   

Abstract

N-acetylaspartate (NAA) has been associated with neuronal integrity and function, and choline-containing compounds have been linked to neuronal membrane integrity. This study examined the influence of the duration of untreated psychosis, duration of prodromal symptoms and total length of untreated illness on these markers of neuronal loss or damage. In vivo 1H magnetic resonance spectroscopy data were acquired from 1.5-cc volumes in the left anterior cingulate and left thalamus of 19 never-treated first episode schizophrenic subjects using STEAM20 at 4.0 Tesla. Duration of untreated psychosis, prodrome and total length of untreated illness were correlated with levels of NAA and choline. No significant correlation was observed between NAA and duration of untreated psychosis and untreated illness in both regions examined. Thalamic NAA negatively correlated with duration of prodromal symptoms. A positive correlation between choline and duration of untreated psychosis was identified in both regions studied. Delays in treatment of psychotic symptoms of schizophrenia were not associated with a reduction in markers of neuronal integrity or function in contrast to longer prodromal periods, which were associated with lower NAA. Neuronal damage, potentially detectable via lower NAA, may be occurring before the onset of psychosis. Increased choline is associated with longer duration of untreated psychosis and could indicate that psychosis-related membrane alterations precede the appearance of NAA reductions observed by studies of chronic schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313517     DOI: 10.1016/j.pscychresns.2004.04.002

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

Review 1.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

Review 2.  A review of altered biochemistry in the anterior cingulate cortex of first-episode psychosis.

Authors:  L Squarcina; J A Stanley; M Bellani; C A Altamura; P Brambilla
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-20       Impact factor: 6.892

Review 3.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

4.  Long term antipsychotic treatment does not alter metabolite concentrations in rat striatum: an in vivo magnetic resonance spectroscopy study.

Authors:  Diana M Lindquist; R Scott Dunn; Kim M Cecil
Journal:  Schizophr Res       Date:  2011-03-22       Impact factor: 4.939

Review 5.  The neurobiology of duration of untreated psychosis: a comprehensive review.

Authors:  Anthony W Zoghbi; Jeffrey A Lieberman; Ragy R Girgis
Journal:  Mol Psychiatry       Date:  2022-08-05       Impact factor: 13.437

6.  Depressive Symptoms and Brain Metabolite Alterations in Subjects at Ultra-high Risk for Psychosis: A Preliminary Study.

Authors:  Min Soo Byun; Jung-Seok Choi; So Young Yoo; Do-Hyung Kang; Chi-Hoon Choi; Dong Pyo Jang; Wi Hoon Jung; Myung Hun Jung; Joon Hwan Jang; Jong-Min Lee; Jun Soo Kwon
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

7.  Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD.

Authors:  Golo Kronenberg; Gabriele Ende; Barbara Alm; Michael Deuschle; Isabella Heuser; Michael Colla
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03-11       Impact factor: 5.270

8.  Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder.

Authors:  Fernando Sarramea Crespo; Rogelio Luque; David Prieto; Pablo Sau; Carmen Albert; Itziar Leal; Ana de Luxan; Maria Isabel Osuna; Miguel Ruiz; Rosa Galán; Francisco Cabaleiro; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

9.  Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia.

Authors:  Agata Szulc; Beata Galińska-Skok; Eugeniusz Tarasów; Beata Konarzewska; Napoleon Waszkiewicz; Rafał Hykiel; Jerzy Walecki
Journal:  Med Sci Monit       Date:  2012-06

10.  Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.

Authors:  James M Stone; Fiona Pepper; Johnson Fam; Hannah Furby; Emer Hughes; Celia Morgan; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2013-11-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.